Current concepts on the pathogenesis of the antiphospholipid syndrome
Authors:
- 19 September 2006
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 109 (2) , 422-430
Abstract
The antiphospholipid syndrome (APS) is an important cause of acquired thrombophilia. It is characterized by the core clinical manifestations of thrombosis, either venous or arterial, and in women it can also be associated with recurrent fetal loss. The detection of persistently elevated levels of antiphospholipid antibodies (aPL Abs) is a requisite laboratory feature for the diagnosis to be made. The dominant antigenic targets in APS are beta 2-glycoprotein I (β2-GPI) and prothrombin. There is an accumulating body of experimental evidence that suggests that specific subgroups of aPL Abs may directly contribute to disease pathogenesis. This review critically examines the experimental evidence underlying the various propositions made to explain how these antibodies may predispose to disease in humans. Furthermore, it also examines the evidence relating to the immunologic mechanisms that may contribute to the breakage of peripheral tolerance in this disorder. Delineating the strengths and limitations of the experimental evidence accumulated thus far will hopefully stimulate further experimentation toward achieving the ultimate goal of precisely defining the dominant pathogenic mechanisms operational in APS. This may pave the way for the development of improved therapies.Keywords
This publication has 97 references indexed in Scilit:
- Binding of β2–glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cellsBlood, 2005
- Domain V of β2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved at Lys317-Thr318Journal of Biological Chemistry, 2005
- Binding of Low Density Lipoprotein to Platelet Apolipoprotein E Receptor 2′ Results in Phosphorylation of p38MAPKJournal of Biological Chemistry, 2004
- Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndromeBlood, 2004
- Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombinArthritis & Rheumatism, 2004
- The effect of phospholipids on the formation of immune complexes between autoantibodies and β2-glycoprotein I or prothrombinClinical Immunology, 2004
- Nicked 2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysisBlood, 2004
- T cells that are autoreactive to β2-glycoprotein I in patients with antiphospholipid syndrome and healthy individualsArthritis & Rheumatism, 2000
- Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c miceArthritis & Rheumatism, 1998
- Anticardiolipin IgG subclasses association of IgG2 with arterial and/or venous thrombosisArthritis & Rheumatism, 1997